People | July 11, 2022
Piramal Pharma strengthens board by inducting three new board members
The appointments will add to the well-diversified experience that currently exists on the PPL board.
The appointments will add to the well-diversified experience that currently exists on the PPL board.
CEPI will provide seed funding of up to US$2.5 million to Codiak BioSciences.
The introduction of Enverse is part of StimLabs' aim to simplify patient care for both physicians and the hospital systems
Sanofi will begin to ship their vaccines helping to ensure more people will be immunized
This facility will produce higher efficacy products that enjoy greater acceptance and enhanced profit marginsg
Most recently, she served as chief human resources officer at Vyripharm Enterprises.
The company is strategically expanding its product portfolio with a pipeline of new products that will form a strong foundation for future growth.
LYNPARZA is approved in the U.S. for patients with HRR gene-mutated mCRPC (BRCA-mutated and other HRR gene mutations)
Revenues from operations for the full year ended March 31, 2022 stood at Rs. 590.05 crore as compared to Rs. 449.82 crore in FY21
The proposed combination involves corporate restructuring of JVCO, including through acquisition by Haleon via demerger
Subscribe To Our Newsletter & Stay Updated
